RXI PHARMACEUTICALS CORP NEW's ticker is RXIIW and the CUSIP is 74979C121. A total of 4 filers reported holding RXI PHARMACEUTICALS CORP NEW in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Anson Funds Management LP | 218,023 | $421,000 | 0.25% |
CVI Holdings, LLC | 221,056 | $55,000 | 0.07% |
SABBY MANAGEMENT, LLC | 196,222 | $49,000 | 0.01% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 3,000 | $1,000 | 0.00% |